241 related articles for article (PubMed ID: 35741027)
1. Primary Human Trophoblasts Mimic the Preeclampsia Phenotype after Acute Hypoxia-Reoxygenation Insult.
Fuenzalida B; Kallol S; Zaugg J; Mueller M; Mistry HD; Gutierrez J; Leiva A; Albrecht C
Cells; 2022 Jun; 11(12):. PubMed ID: 35741027
[TBL] [Abstract][Full Text] [Related]
2. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
3. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
[TBL] [Abstract][Full Text] [Related]
4. Effects of sirtuin 1 deficiency on trophoblasts and its implications in the pathogenesis of pre-eclampsia.
Yu H; Chen L; Du P; Liu X; Xia Y
J Obstet Gynaecol; 2023 Dec; 43(2):2282103. PubMed ID: 37966393
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.
Ye L; Gratton A; Hannan NJ; Cannon P; Deo M; Palmer KR; Tong S; Kaitu'u-Lino TJ; Brownfoot FC
Placenta; 2016 Dec; 48():110-118. PubMed ID: 27871461
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.
Li H; Gu B; Zhang Y; Lewis DF; Wang Y
Placenta; 2005; 26(2-3):210-7. PubMed ID: 15708122
[TBL] [Abstract][Full Text] [Related]
7. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
8. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
[TBL] [Abstract][Full Text] [Related]
9. Trimethylamine N-Oxide increases soluble fms-like tyrosine Kinase-1 in human placenta via NADPH oxidase dependent ROS accumulation.
Chang QX; Chen X; Ming-Xin Yang ; Zang NL; Li LQ; Zhong N; Xia LX; Huang QT; Zhong M
Placenta; 2021 Jan; 103():134-140. PubMed ID: 33120049
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.
Huang QT; Zhang M; Zhong M; Yu YH; Liang WZ; Hang LL; Gao YF; Huang LP; Wang ZJ
Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948
[TBL] [Abstract][Full Text] [Related]
11. Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy.
Zamudio S; Borges M; Echalar L; Kovalenko O; Vargas E; Torricos T; Khan AA; Alvarez M; Illsley NP
Biol Reprod; 2014 Feb; 90(2):42. PubMed ID: 24352559
[TBL] [Abstract][Full Text] [Related]
12. Bioflavonoid luteolin prevents sFlt-1 release via HIF-1α inhibition in cultured human placenta.
Eddy AC; Chiang CY; Rajakumar A; Spradley FT; Dauer P; Granger JP; Rana S
FASEB J; 2023 Aug; 37(8):e23078. PubMed ID: 37405762
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
[TBL] [Abstract][Full Text] [Related]
14. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction.
Lorenz-Meyer LA; Frank L; Sroka D; Busjahn A; Henrich W; Verlohren S
Pregnancy Hypertens; 2022 Jun; 28():149-155. PubMed ID: 35453103
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia.
Liu X; Deng Q; Luo X; Chen Y; Shan N; Qi H
J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3776-85. PubMed ID: 26809169
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lectin-like oxidized low-density lipoprotein receptor 1 protects against plasma/hypoxia-mediated trophoblast dysfunction associated with preeclampsia.
Zhang Y; Ye Y; Wang Y; Chen W
Gynecol Obstet Invest; 2015; 79(2):90-6. PubMed ID: 25633310
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
[TBL] [Abstract][Full Text] [Related]
18. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.
Jena MK; Sharma NR; Petitt M; Maulik D; Nayak NR
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599856
[TBL] [Abstract][Full Text] [Related]
20. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
